FDA Inspection 1271627 — Schwabe North America, Inc.

Schwabe North America, Inc. — FEI 2128693

The FDA completed an inspection of Schwabe North America, Inc. on August 28, 2025 in Green Bay, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 28, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Green Bay, WI (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures